FOGHORN THERAPEUTICS INC's ticker is FHTX and the CUSIP is 344174107. A total of 64 filers reported holding FOGHORN THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $50,725 | -26.4% | 10,145 | +3.7% | 0.00% | – |
| Q2 2023 | $68,886 | +14.6% | 9,785 | +0.9% | 0.00% | – |
| Q1 2023 | $60,128 | -0.9% | 9,698 | +2.0% | 0.00% | – |
| Q4 2022 | $60,648 | -26.0% | 9,506 | -0.4% | 0.00% | -100.0% |
| Q3 2022 | $82,000 | -35.9% | 9,540 | +1.4% | 0.00% | 0.0% |
| Q2 2022 | $128,000 | -13.5% | 9,405 | -3.2% | 0.00% | 0.0% |
| Q1 2022 | $148,000 | -37.8% | 9,712 | -6.6% | 0.00% | 0.0% |
| Q4 2021 | $238,000 | +59.7% | 10,395 | -2.9% | 0.00% | 0.0% |
| Q3 2021 | $149,000 | +27.4% | 10,706 | -2.3% | 0.00% | – |
| Q2 2021 | $117,000 | +112.7% | 10,960 | +161.5% | 0.00% | – |
| Q1 2021 | $55,000 | -35.3% | 4,192 | +0.3% | 0.00% | – |
| Q4 2020 | $85,000 | – | 4,181 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Capital LLC | 1,261,261 | $16,623,000 | 5.56% |
| Flagship Pioneering Inc. | 12,674,120 | $167,045,000 | 2.68% |
| Birchview Capital, LP | 314,143 | $4,140,000 | 2.46% |
| Monashee Investment Management LLC | 530,581 | $6,993,000 | 1.08% |
| Artal Group S.A. | 1,720,720 | $22,679,000 | 0.40% |
| Octagon Capital Advisors LP | 69,132 | $911,000 | 0.34% |
| Cormorant Asset Management, LP | 1,000,000 | $13,180,000 | 0.29% |
| Alphabet Inc. | 500,901 | $6,602,000 | 0.27% |
| Casdin Capital, LLC | 216,216 | $2,850,000 | 0.08% |
| Board of Trustees of The Leland Stanford Junior University | 30,657 | $404,000 | 0.04% |